CBT (STOCKS)
Cabot Corporation
$75.930000
+0.170000 (+0.22%)
Prev close: $75.760000
Company Information
- Exchange
- XNYS
- Sector
- Process Industries
- Industry
- Chemicals: Specialty
- CEO
- Sean D. Keohane
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,026.86M
- Employees
- 4,200
- P/E (TTM)
- 13.30
- P/B (TTM)
- 2.51
- Dividend Yield
- 234.95%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
3
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$1.53 | $1.42 | +0.1077 | +7.57% |
|
Sep 2025 (Q4)
|
$1.70 | $1.70 | +0.0006 | +0.04% |
|
Jun 2025 (Q3)
|
$1.90 | $1.84 | +0.0586 | +3.18% |
|
Mar 2025 (Q2)
|
$1.90 | $1.87 | +0.0269 | +1.44% |
Financial Statements
| Revenues | $3.61B |
| Benefits Costs and Expenses | $3.07B |
| Cost Of Revenue | $2.69B |
| Costs And Expenses | $3.07B |
| Gross Profit | $916.00M |
| Operating Expenses | $321.00M |
| Selling, General, and Administrative Expenses | $263.00M |
| Research and Development | $58.00M |
| Operating Income/Loss | $595.00M |
| Income/Loss Before Equity Method Investments | $539.00M |
| Income/Loss From Continuing Operations After Tax | $350.00M |
| Income/Loss From Continuing Operations Before Tax | $539.00M |
| Income/Loss From Equity Method Investments | $7.00M |
| Income Tax Expense/Benefit | $192.00M |
| Interest Expense, Operating | $76.00M |
| Net Income/Loss | $354.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $43.00M |
| Net Income/Loss Attributable To Parent | $311.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $306.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $6.00M |
| Preferred Stock Dividends And Other Adjustments | $3.00M |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $4.00M |
| Basic Earnings Per Share | $5.76 |
| Diluted Earnings Per Share | $5.72 |
| Basic Average Shares | 160,000,000 |
| Diluted Average Shares | 160,900,000 |
| Common Stock Dividends | $1.78 |
| Assets | $3.76B |
| Current Assets | $1.46B |
| Inventory | $503.00M |
| Other Current Assets | $954.00M |
| Noncurrent Assets | $2.30B |
| Fixed Assets | $1.73B |
| Other Non-current Assets | $573.00M |
| Liabilities | $2.03B |
| Current Liabilities | $874.00M |
| Noncurrent Liabilities | $1.15B |
| Equity | $1.73B |
| Equity Attributable To Noncontrolling Interest | $154.00M |
| Equity Attributable To Parent | $1.58B |
| Liabilities And Equity | $3.76B |
| Net Cash Flow From Operating Activities | $667.00M |
| Net Cash Flow From Operating Activities, Continuing | $667.00M |
| Net Cash Flow From Investing Activities | -$263.00M |
| Net Cash Flow From Investing Activities, Continuing | -$263.00M |
| Net Cash Flow From Financing Activities | -$404.00M |
| Net Cash Flow From Financing Activities, Continuing | -$404.00M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | $513.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $55.00M |
| Comprehensive Income/Loss Attributable To Parent | $458.00M |
| Other Comprehensive Income/Loss | $159.00M |